Not logged in...
About USC Norris
FAQ - Trials
Contact Us - Trials
Support USC Norris
» Contact Us
If you are a patient, please contact
Keck Medical Center of USC
An Open-Label Phase IIIB Study of Regorafenib in Patients with Metastatic Colorectal Cancer (CRC) Who Have Progressed After Standard Therapy.
Closed to Accrual with Ongoing Follow-up
Anti-Angiogenesis, Chemotherapy: Systemic
Defintions of terms and FAQ about clinical trials.
Heinz Josef Lenz, M.D.
Other Trial Staff:
Ramona Lujan, R.N., Raluca Agafitei, Coordinator, Mary Ordaz, D.M., Carol Jones, R.N., Taison Tran, D.M.
to see study documents.
Click here to see trial eligibility criteria and further details at ClinicalTrials.gov
For further information on a study, please contact the Clinical Investigation Support Office at (323) 865-0451, or
To schedule a consultation with the hospital, please call our New Patient Referrals Office at (323) 865-3111.